Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1633 1663
This examiner grants 21% of resolved cases
Ileana Popa is an examiner in Tech Center 1600, Art Unit 1600, with 845 resolved cases. She has a low allowance rate of 21.4 percent, which indicates a difficult path for applicants. The median time to allowance is 1715 days, reflecting a very long and potentially arduous prosecution process. This timeline suggests that applications often face a rigorous review before any possibility of a grant.
The interview lift for this examiner is 15.1 percent. While this lift is significant relative to the 21.4 percent allowance rate, the overall chances of success remain low. Practitioners should be prepared for a long-term commitment, as shown by the 1715-day median pendency. With 845 resolved cases, the examiner's data shows a consistent pattern of high scrutiny and slow resolution in Art Unit 1600. An interview may be a necessary step to try and improve the low probability of allowance.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18711131 | Method of Treating Geographic Atrophy with a Gene Therapy Vector Expressing Soluble CD59 | Non-Final OA | Janssen Biotech, Inc. |
| 18583364 | Neoantigens Expressed In Ovarian Cancer And Their Uses | Non-Final OA | Janssen Biotech, Inc. |
| 18088544 | POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY | Final Rejection | University of Massachusetts |
| 16623268 | MATERIALS AND METHODS FOR INCREASING IMMUNE RESPONSES | Final Rejection | Mayo Foundation for Medical Education and Research |
| 17925470 | FUNCTIONAL LIPID DERIVATIVES AND USES THEREOF | Final Rejection | Ohio State Innovation Foundation |
| 18022415 | METHOD FOR IN VITRO PRODUCTION OF RED BLOOD CELLS | Final Rejection | IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) |
| 16813263 | Methods of Generating Mature Human Muscle Fibers | Non-Final OA | University of Maryland, Baltimore |
| 18590366 | THERAPEUTIC AGENT FOR ARTHROSIS AND PRODUCTION METHOD FOR THERAPEUTIC AGENT FOR ARTHROSIS | Non-Final OA | National University Corporation Tokyo Medical and Dental University |
| 18555385 | SIGNAL PEPTIDES | Non-Final OA | IMPERIAL COLLEGE INNOVATIONS LIMITED |
| 15327794 | SUBSET-OPTIMIZED CHIMERIC ANTIGEN RECEPTOR-CONTAINING T-CELLS | Final Rejection | The Trustees of the University of Pennsylvania |
| 18068922 | MAMMALIAN CELL CULTURE | Non-Final OA | AMGEN INC. |
| 18249037 | GLYCOSYLTRANSFERASE VARIANTS FOR IMPROVED PROTEIN PRODUCTION | Final Rejection | Novozymes A/S |
| 18289028 | COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING STEREOCILIN DUAL VECTOR SYSTEMS | Non-Final OA | Decibel Therapeutics, Inc. |
| 18465333 | COMPOSITONS AND METHODS FOR USE OF KALIUM CHANNEL RHODOPSINS | Non-Final OA | BAYLOR COLLEGE OF MEDICINE |
| 18003646 | C825 EXPRESSING IMMUNE CELLS AND DIAGNOSTIC USES THEREOF | Non-Final OA | Memorial Sloan Kettering Cancer Center |
| 17765507 | METHOD FOR PRODUCING HEPARIN-LIKE SUBSTANCE, RECOMBINANT CELL, AND METHOD FOR PRODUCING THE SAME | Non-Final OA | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION |
| 18890983 | STEREOCHEMICALLY ENRICHED COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS | Non-Final OA | TRANSLATE BIO, INC. |
| 17450629 | PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES | Non-Final OA | Translate Bio, Inc. |
| 18816718 | T CELLS FOR EXPRESSION OF CHIMERIC ANTIGEN RECEPTORS AND OTHER RECEPTORS | Non-Final OA | City of Hope |
| 18093902 | METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR-REACTIVE T CELLS FROM TUMOR | Non-Final OA | The United States of America,as represented by the Secretary,Department of Health and Human Services |
| 18375392 | METHODS FOR PRODUCING SINGLE INSECT CELL CLONES | Final Rejection | uniQure biopharma B.V. |
| 17273724 | MATERIALS AND METHODS FOR THE CORRECTION OF RETINITIS PIGMENTOSA | Non-Final OA | BLUEALLELE, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy